Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2878 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
filingDate |
2017-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_997a38927019d369afa1ae2bae727070 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25fc80eb152863b9cad29d806750a467 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_845d73ff09515a3da34e07741997f0ec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15b17c1e19e5003541b6c45a264b9202 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e075762722a758831d117386acd4fa37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc751d9a817b64ccefe184921d7354af http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_074825d84aa5c0ab9ff46ee440d29a53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a768e1bbb0b269905d563aaa0971b5e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f7da6fe5bf48555a69ddd49e07783e8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0120ff88adcc0cb48fddf9631ca72fb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7077e025d7f98d96aa630986a3a451f |
publicationDate |
2019-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-110582513-A |
titleOfInvention |
Bispecific binding molecules against TNF-related apoptosis-inducing ligand receptor 2 and anti-cadherin-17 for the treatment of cancer |
abstract |
The present invention relates to a binding molecule that specifically binds to TNF-related apoptosis-inducing ligand receptor 2 (TNF-related apoptosis-inducing ligand receptor 2; TRAILR2) and cadherin-17 (cadherin-17; CDH17) and a binding molecule thereof. Use in medicaments, pharmaceutical compositions comprising the binding molecules and methods of using the binding molecules as medicaments for the treatment and/or prevention of cancer. |
priorityDate |
2016-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |